Literature DB >> 3203176

Amantadine for the agitated head-injury patient.

M C Chandler1, J L Barnhill, C T Gualtieri.   

Abstract

Traumatic brain injury may be associated with agitated aggressive behaviour and the potential for injury to the patient and staff. We report two cases of recovering brain injury patients with difficult-to-treat destructive behaviour, whose agitation and aggression responded to amantadine. Direct-acting dopamine agonists such as amantadine may be the preferred treatment for patients with behaviour problems in the acute stages of recovery from coma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3203176     DOI: 10.3109/02699058809150901

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  8 in total

1.  Targeting Dopamine in Acute Traumatic Brain Injury.

Authors:  James W Bales; Anthony E Kline; Amy K Wagner; C Edward Dixon
Journal:  Open Drug Discov J       Date:  2010

Review 2.  Catecholaminergic based therapies for functional recovery after TBI.

Authors:  Nicole D Osier; C Edward Dixon
Journal:  Brain Res       Date:  2015-12-19       Impact factor: 3.252

Review 3.  Biologic and plastic effects of experimental traumatic brain injury treatment paradigms and their relevance to clinical rehabilitation.

Authors:  Alexandra N Garcia; Mansi A Shah; C Edward Dixon; Amy K Wagner; Anthony E Kline
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

4.  Amantadine: a review of use in child and adolescent psychiatry.

Authors:  Sheik Hosenbocus; Raj Chahal
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2013-02

Review 5.  Amantadine and Modafinil as Neurostimulants During Post-stroke Care: A Systematic Review.

Authors:  David J Gagnon; Angela M Leclerc; Richard R Riker; Caitlin S Brown; Teresa May; Kristina Nocella; Jennifer Cote; Ashley Eldridge; David B Seder
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.210

Review 6.  Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis.

Authors:  James W Bales; Amy K Wagner; Anthony E Kline; C Edward Dixon
Journal:  Neurosci Biobehav Rev       Date:  2009-04-01       Impact factor: 8.989

7.  Placebo-controlled trial of oral amantadine and zolpidem efficacy on the outcome of patients with acute severe traumatic brain injury and diffuse axonal injury.

Authors:  Sajad Shafiee; Saeed Ehteshami; Mahmood Moosazadeh; Saeed Aghapour; Kaveh Haddadi
Journal:  Caspian J Intern Med       Date:  2022

Review 8.  Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.

Authors:  Wojciech Danysz; Andrzej Dekundy; Astrid Scheschonka; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2021-02-23       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.